Atrial Fibrillation in Cancer Patients: Who is at Risk?
Cancer is the second leading cause of mortality in the world, second only to cardiovascular diseases. Simultaneously cancer mortality has been steadily decreasing due to the development of new chemotherapy and targeted drugs and the improvement of existing treatment protocols. Improving the pr...
Saved in:
Main Authors: | Yu. A. Vasyuk (Author), E. Yu. Shupenina (Author), D. A. Vyzhigin (Author), E. O. Novosel (Author), K. V. Gallinger (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vasotoxic Effects of Anticancer Therapy: a Review of Current Data
by: Yu. A. Vasyuk, et al.
Published: (2023) -
Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
by: E. S. Mazur, et al.
Published: (2022) -
Drug-Induced Atrial Fibrillation / Atrial Flutter
by: O. D Ostroumova, et al.
Published: (2022) -
GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016) -
APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
by: E. A. Ushkalova, et al.
Published: (2017)